Immunosuppressive therapy in patients with connective tissue disease-associated pulmonary arterial hypertension: A systematic review.

Yufang DingJunyan QianShangzhu ZhangDong XuXiaomei LengJiuliang ZhaoQian Wang Wen Zhang Xinping TianMengtao LiXiaofeng Zeng

Published in: International journal of rheumatic diseases (2022)

Current studies support the use of immunosuppressive therapy in CTD-PAH, especially in SLE-PAH. Further studies on biological agents and the therapeutic effect of different immunosuppressants are still needed.

Keyphrases

pulmonary arterial hypertension
pulmonary artery
pulmonary hypertension
case control
systemic lupus erythematosus
polycyclic aromatic hydrocarbons
stem cells
disease activity
coronary artery